VOYA Investment Management
UTHR icon

VOYA Investment Management’s United Therapeutics UTHR Stock Holding History

VOYA Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.2M Sell
13,289
-11,199
-46% -$6.31M 0.01% 733
2026
Q1 		$14.5M Sell
24,488
-6,047
-20% -$3.01M 0.02% 526
2025
Q4 		$14.9M Sell
30,535
-3,149
-9% -$1.47M 0.01% 563
2025
Q3 		$14.1M Sell
33,684
-3,458
-9% -$1.16M 0.01% 575
2025
Q2 		$10.7M Sell
37,142
-7,453
-17% -$2.23M 0.01% 714
2025
Q1 		$13.7M Buy
44,595
+6,047
+16% +$2.07M 0.02% 649
2024
Q4 		$13.6M Buy
38,548
+1,581
+4% +$581K 0.01% 660
2024
Q3 		$13.2M Buy
36,967
+5,930
+19% +$2M 0.01% 676
2024
Q2 		$9.89M Buy
31,037
+608
+2% +$161K 0.01% 757
2024
Q1 		$6.99M Sell
30,429
-121,359
-80% -$27.4M 0.01% 872
2023
Q4 		$33.4M Sell
151,788
-1,372
-0.9% -$316K 0.03% 414
2023
Q3 		$34.6M Sell
153,160
-4,518
-3% -$1.04M 0.04% 386
2023
Q2 		$34.8M Sell
157,678
-36,957
-19% -$8.19M 0.04% 401
2023
Q1 		$43.6M Buy
194,635
+6,865
+4% +$1.69M 0.05% 367
2022
Q4 		$52.2M Sell
187,770
-29,353
-14% -$7.41M 0.06% 331
2022
Q3 		$45.5M Buy
217,123
+14,795
+7% +$3.31M 0.05% 336
2022
Q2 		$47.7M Sell
202,328
-7,228
-3% -$1.47M 0.12% 169
2022
Q1 		$37.6M Sell
209,556
-5,622
-3% -$1.07M 0.08% 216
2021
Q4 		$46.5M Sell
215,178
-51,302
-19% -$10.1M 0.09% 198
2021
Q3 		$49.2M Sell
266,480
-32,836
-11% -$6.47M 0.1% 192
2021
Q2 		$53.7M Buy
299,316
+279,084
+1,379% +$53.2M 0.1% 194
2021
Q1 		$3.38M Buy
20,232
+1,324
+7% +$221K 0.01% 978
2020
Q4 		$2.87M Sell
18,908
-830
-4% -$109K 0.01% 996
2020
Q3 		$1.99M Sell
19,738
-728
-4% -$79.9K ﹤0.01% 1033
2020
Q2 		$2.48M Buy
20,466
+9,353
+84% +$1.05M 0.01% 952
2020
Q1 		$1.05M Buy
11,113
+3,516
+46% +$334K ﹤0.01% 1197
2019
Q4 		$669K Sell
7,597
-63
-0.8% -$5.54K ﹤0.01% 1711
2019
Q3 		$611K Hold
7,660
– – ﹤0.01% 1624
2019
Q2 		$598K Sell
7,660
-21,365
-74% -$2M ﹤0.01% 1658
2019
Q1 		$3.41M Sell
29,025
-1,172
-4% -$137K 0.01% 899
2018
Q4 		$3.29M Sell
30,197
-239
-0.8% -$27.7K 0.01% 874
2018
Q3 		$3.89M Sell
30,436
-756
-2% -$93.5K 0.01% 902
2018
Q2 		$3.53M Sell
31,192
-3,590
-10% -$395K 0.01% 912
2018
Q1 		$3.91M Sell
34,782
-269
-0.8% -$34.2K 0.01% 873
2017
Q4 		$5.19M Buy
35,051
+23,045
+192% +$2.93M 0.01% 811
2017
Q3 		$1.41M Sell
12,006
-47,744
-80% -$6.1M ﹤0.01% 1208
2017
Q2 		$7.75M Buy
59,750
+14,136
+31% +$1.76M 0.02% 675
2017
Q1 		$6.17M Buy
45,614
+30,531
+202% +$4.63M 0.01% 744
2016
Q4 		$2.16M Sell
15,083
-28,919
-66% -$3.69M 0.01% 1010
2016
Q3 		$5.2M Buy
44,002
+531
+1% +$63.8K 0.01% 786
2016
Q2 		$4.6M Buy
43,471
+12,636
+41% +$1.41M 0.01% 801
2016
Q1 		$3.44M Sell
30,835
-774
-2% -$97.9K 0.01% 855
2015
Q4 		$4.95M Buy
31,609
+4,527
+17% +$659K 0.01% 780
2015
Q3 		$3.56M Sell
27,082
-117
-0.4% -$18.8K 0.01% 847
2015
Q2 		$4.73M Buy
27,199
+278
+1% +$50K 0.01% 801
2015
Q1 		$4.64M Buy
26,921
+3,957
+17% +$603K 0.01% 823
2014
Q4 		$2.97M Sell
22,964
-11,026
-32% -$1.42M 0.01% 961
2014
Q3 		$4.37M Sell
33,990
-45,107
-57% -$4.65M 0.01% 836
2014
Q2 		$7M Buy
79,097
+13,712
+21% +$1.32M 0.02% 723
2014
Q1 		$6.15M Buy
65,385
+11,994
+22% +$1.23M 0.01% 739
2013
Q4 		$6.04M Sell
53,391
-1,874
-3% -$169K 0.01% 743
2013
Q3 		$4.36M Sell
55,265
-56
-0.1% -$4.09K 0.01% 815
2013
Q2 		$3.64M Buy
+55,321
New +$3.56M 0.01% 857

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

VOYA Investment Management's UTHR Position: Q2 2026 in Review

VOYA Investment Management reduced its United Therapeutics (UTHR) stake by 46% in Q2 2026, selling an estimated $6.31M and leaving 13,289 shares worth $7.2M. The position accounts for 0.01% of the portfolio, ranked #733.

VOYA Investment Management first reported a position in UTHR in Q2 2013 and has held it in 53 quarters since. The position peaked at $53.7M in Q2 2021. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • VOYA Investment Management held 13,289 shares of United Therapeutics worth $7.2M as of Q2 2026.
  • VOYA Investment Management sold 11,199 United Therapeutics shares in Q2 2026, an estimated $6.31M.
  • United Therapeutics made up 0.01% of VOYA Investment Management's portfolio in Q2 2026, its #733 holding.
  • VOYA Investment Management first reported a position in United Therapeutics in Q2 2013 and has held it in 53 quarters since.
  • VOYA Investment Management's United Therapeutics position peaked at $53.7M in Q2 2021.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.